Brain Tumor Symposium 2026

1. Discuss current molecular pathology updates for patients.
2. Identify emerging local and systemic molecularly treatment options for patients with gliomas.
3. Discuss emerging role of cellular therapy in CNS tumors.
4. Identify role of Radiation Oncology with precision medicine in CNS tumors.
5. Discuss emerging role of viral therapy and focused ultrasound in CNS tumor.
6. Identify standard and advancements in Radiation Oncology for Pediatric Neuro-Oncology.
7. Discuss advancements of targeted therapy for CNS Metastases.
8. Identify advancements in skull based tumor approaches.
9. Describe the role of integrative and palliative medicine to improve quality of life for patients with CNS tumors.

The University of Florida College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation

The University of Florida College of Medicine designates this Live Activity for a maximum of 7.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Cancellation Policy
Written refund requests must be received on or before September 25, 2026. A $50 processing fee will be deducted from refund requests. NO REFUNDS WILL BE GIVEN AFTER September 25, 2026. Substitutions are allowed with advance notice. Refund and/or substitution requests must be received in writing by email.

In the event of postponement or cancellation, a full refund will be given. The University of Florida is not responsible for travel arrangements, travel fees, or any expenses incurred by you as a result of such a cancellation. If the University of Florida cancels this event, you will be contacted at the email address you provided, so please be sure to provide a valid email address.

Accommodations for Disabilities or Special Requests, Including Dietary
If you have needs that require special accommodations, including dietary concerns, please contact the CME Office.

For questions, please contact
Email: [email protected]

Mitigation of Relevant Financial Relationships

University of Florida College of Medicine adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. All individuals in a position to control a CME activity's content, including faculty, planners, reviewers, and/or others, must disclose all financial relationships with ineligible companies (commercial interests). Conflict of interest information for the CME Advisory Committee members can be found on the following website: https://cme.ufl.edu/disclosure. No one else in a position to control content has any financial relationships to disclose. All relevant financial relationships have been mitigated.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

Anastacia Cantrell, MPMT
Conference Planner
College of Medicine

Activity Administrator

Nothing to disclose

Ashley Ghiaseddin, MD
University of Florida College of Medicine

Course Director

Consulting Fee-Alexion Pharmaceuticals (Relationship has ended)|Consulting Fee-Monteris Medical|Consulting Fee-Neosoma|Consulting Fee-Novocure|Grant or research support-Novocure|Consulting Fee-Neosoma|Consulting Fee-Deciphera|Consulting Fee-Telix Pharmaceuticals|Consulting Fee-NuvationBio|Grant or research support-NuvationBio|Stocks or stock options, excluding diversified mutual funds-CRISPR Therapeutics AG|Stocks or stock options, excluding diversified mutual funds-Prime Medicine Inc.

Maryam Rahman, MD
University of Florida

Other Planning Committee Member

Nothing to disclose

The full exhibit prospectus is available on the conference website. Please feel free to contact us if you have any questions!